Background : A multicenter study conducted in Southeast Asia to derive reference intervals (RIs) for 72 commonly measured analytes (general chemistry, inflammatory markers, hormones, etc.) featured centralized measurement to clearly detect regionality in test results. The results of 31 standardized analytes are reported, with the remaining analytes presented in the next report. Method : The study included 63 clinical laboratories from South Korea, China, Vietnam, Malaysia, Indonesia, and seven areas in Japan. A total of 3541 healthy individuals aged 20 -65 years (Japan 2082, others 1459) were recruited mostly from hospital workers using a well-defined common protocol. All serum specimens were transported to Tokyo at − 80 ° C and collectively measured using reagents from four manufacturers. Three-level nested ANOVA was used to quantitate variation (SD) of test results due to region, sex, and age. A ratio of SD for a given factor over residual SD (representing net between-individual variations) (SDR) exceeding 0.3 was considered significant. Traceability of RIs was ensured by recalibration using value-assigned reference materials. RIs were derived parametrically. Results : SDRs for sex and age were significant for 19 and 16 analytes, respectively. Regional difference was significant for 11 analytes, including high density lipoprotein (HDL)-cholesterol and inflammatory markers. However, when the data were limited to those from Japan, regionality was not observed in any of the analytes. Accordingly, RIs were derived with or without partition by sex and region. Conclusions : RIs applicable to a wide area in Asia were established for the majority of analytes with traceability to reference measuring systems, whereas regional partitioning was required for RIs of the other analytes.
Introduction
The global standardization of laboratory tests for major analytes has been achieved by the efforts of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and its national member organizations [ 1 ] . However, reference intervals (RIs) still frequently differ from one laboratory to another. According to the directive on in vitro diagnostic medical devices of the European Union [ 2 ] , diagnostic manufacturers are now requested to supply their clients with appropriate RIs attached to their reagents, and the ISO 15189 standard for clinical laboratory accreditation claims that the laboratory should periodically re-evaluate its RIs [ 3 ] . However, despite these requirements, there have been only a limited number of attempts to conduct appropriate multicenter studies to achieve this goal [ 4 − 6 ] . Most studies to date were conducted by gathering test results of healthy donors ' specimens measured at each participating laboratory. This relies on two main assumptions: comparability of assay results across different laboratories and lack of regionality in test results. Validation of these assumptions, however, is not easy and thus, the interpretation of RIs is not straightforward.
One multicenter study was conducted in six Asian cites by the Committee on Plasma Proteins (C-PP) of the IFCC Scientific Division (IFCC-SD) in 2000 to derive common reference intervals for 14 major serum proteins [ 7 ] whose standardization had almost been achieved by the availability of certified reference material 470 (CRM470) produced under the direction of the C-PP [ 8 ] . This study adopted a different approach, that of centralized measurement, by sending all of the specimens to one center in Japan and measuring them collectively in a single laboratory. Unexpectedly, it revealed large interregion variation for many analytes belonging to the class of inflammatory markers, such as IgG, C3, and CRP [ 7 ] . To confirm these findings, another study was conducted in 2006 with the participation of six other centers belonging to the Asia Pacific Federation of Clinical Biochemistry (APFCB) [ 9 ] . A total of 560 healthy individuals, mainly those working in clinical laboratories, donated blood to allow measurement of 32 common analytes (22 biochemical analytes and 10 proteins). This second survey confirmed significant regionality in about one third of the analytes examined.
Prompted by these observations, this present third study was planned jointly by the C-PP, the Committee on Reference Intervals and Decision Limits (C-RIDL) of the IFCC-SD, and by the Scientific Committee of the APFCB. The primary goal was to verify the possibility of establishing common RIs (i.e., RIs that can be applied to the entire population, independently from the analytical method in use [ 10 ] ) for the standardized analytes by ensuring traceability of test results. To do this, we collected samples from several relatively homogenous groups of individuals in Japan and in Southeast Asia together with a considerable amount of information allowing us to put in evidence regarding possible effects due to environment and/or lifestyle. Thus, we were able to investigate biological sources of variations in each analyte, including the presence of differences in RIs related to geographical areas (regionality). Our work was not limited to well-standardized analytes but also included non-standardized analytes mostly measured by immunoassays, such as tumor markers, and hormones. To achieve these goals, we again adopted the centralized measurement approach to eliminate assay-related variations. For clarity of presentation, we report herein the results limited to 31 standardized analytes and leave results of other analytes to the next report.
Materials and methods

Participating centers
Invitations to the study together with its protocol were sent to clinical laboratories of major hospitals and commercial laboratories in countries belonging to the APFCB. Fift een laboratories located in Seoul, Beijing, Taipei, Tainan, Ho Chi Minh City, Kuala Lumpur, Hong Kong, Macau, and Jakarta accepted the invitation. In Japan, collaboration was obtained nationwide from 47 laboratories. All laboratories are listed in the Acknowledgments.
Target population and sample size
We limited the population mainly to those working in clinical laboratories or hospitals to eliminate the potential infl uence of diff erences in job profi les on the test results. A minimum sample size from each local area was set at 120 samples to gain adequate statistical power to detect diff erences among areas. Usually two or more laboratories from each city collaborated to achieve the target number. The age range of donors was set at 20 -65 years. The utmost eff ort was made to ensure an even distribution of age and an equal male to female ratio.
The following exclusion criteria were applied at the time of recruitment: 1) body mass index (BMI) ≥ 28 kg/m 2 ; 2) average daily consumption of ethanol ≥ 75 g [this amount of alcohol intake is rather high, but it was decided to leave it as a general criterion to evaluate the eff ect of alcohol assumption and to adopt specifi c exclusion criteria for analytes known to be infl uenced by alcohol intake (e.g., ALT, GGT, etc.)], 3) cigarette smoking > 20/day, 4) regular medication for chronic disease (diabetes mellitus, hypertension, hyperlipidemia, allergic disorders, etc.), 5) recent ( ≤ 2 weeks) recovery from acute illness or surgery requiring hospitalization, 6) known hepatitis B or C virus carrier, and 7) pregnancy or within 1 year aft er childbirth.
For analysis of sources of variation for each analyte, a healthstatus survey was conducted via questionnaire to obtain information on BMI, ABO blood type, eating patterns, recent episodes of infection or allergy, menstrual status, and other factors. Written informed consent was obtained from each volunteer. The specimens, the test results, and questionnaires were processed anonymously by assigning sequential numbers on arrival to each individual. Aft er completion of measurement for major analytes, the test results together with newly derived sex-specifi c RIs were reported confi dentially.
The study was approved by the Ethical Committee of Yamaguchi University Graduate School of Medical Sciences in December, 2008. The other collaborative laboratories followed their own rules in taking part in the study.
Collection of blood samples
Prior to blood sampling, each volunteer was requested to avoid strenuous physical exertion/exercise during the preceding 4 days, excessive eating or drinking the night before, and to fast overnight at least for 10 h.
Venipuncture was done between 7 am and 10 am aft er the donor sat quietly for at least 15 min to avoid variations of test results due to physical activity and postural infl uence. Blood in the amount of 17 mL was drawn from each donor. All participating laboratories received the same blood drawing set containing the vacuum sampling system, provided by Becton-Dickinson Corp. (BD), (Franklin Lakes, NJ, USA), including BD Vacutainer SST tubes (capacity: 8.5 mL) containing a clot-activator and CryoTube cryovials (capacity: 4.8 mL) (Nunc, Roskilde, Denmark). Aft er blood collection, the tubes were rocked 180 ° at least fi ve times, and centrifugation for serum separation was done within 2 h of collection. The separated serum was transferred and aliquoted immediately to the freezing vials for storage at − 80 ° C. As an adjunct test, a peripheral blood count (CBC) in EDTA-2K blood was performed locally. The results were used as criteria to exclude those who were anemic. The CBC test results were obtained from 1978 individuals in laboratories that used the BeckmanCoulter hematology analyzer [Beckman Coulter Inc. (BC), Brea, CA, USA] for their routine assays.
Target analytes and measurements
Seventy-two analytes (lipids, electrolytes, enzymes, tumor markers, hormones, vitamins, etc.) were targeted for collective measurements. Assay methods, reference materials, and their precisions for the 31 standardized analytes included in this report are listed in Table 1 . The auto-analyzer used in the centralized assays was the UniCel DxC (BC). Enzyme activities except for amylase (AMY) were measured in duplicate, one by the IFCC-and the other by JSCC (Japan Society for Clinical Chemistry)-recommended method. The assays were done at BC Japan ' s Central Laboratory located in Ariake, Tokyo, using the manufacturer ' s reagents, calibrators, and controls, unless otherwise indicated.
For quality control monitoring, a set of four fresh-frozen pooled sera from healthy individuals, stored aliquoted at − 80 ° C, were used to evaluate imprecision of assays. The average results of imprecision using these samples are listed in Table 1 .
Specimen transportation
Serum specimens were packed in a styrene foam box container fi lled with dry ice and transported to the central laboratory by a domestic express courier service within Japan. Outside Japan, the sample containers were picked up from each laboratory by the coordinator of this study and transported to Japan by airplane, carried as check-in baggage.
Verification of traceability
Reference methods and/or materials for the 31 analytes are available in the database of the Joint Committee on Traceability of Laboratory Medicine (JCTLM). We checked traceability to the corresponding reference system using the materials or methods listed in Table 1 . When reference laboratory services were involved (enzymes and hormones), a set of three fresh-frozen ( − 80 ° C) pooled sera for each enzyme (AST, ALT, LD, GGT, and CK), or fi ve to nine levels of lyophilized specimens (for the four steroid hormones), were fi rst value-assigned by the reference laboratories (see Acknowledgments) and then used to check alignment of the analytical systems used for obtaining reference used for recalibration were pooled sera of three concentrations, which were prepared for each enzyme, and values were assigned by the reference measurement system (RMS); c used for recalibration were lyophilized specimens of five to eight concentrations that were value-assigned by RMS; d
The analyte was measured in specimens collected without addition of sodium fluoride. The result was used as one of the exclusion criteria.
values. Particularly, recalibration of test results was made based on the experimental relation between the assigned values and the test results (measured on three separate days, each in triplicate) obtained at BC ' s laboratory in Tokyo. When there were more than two levels of reference materials, the regression line to be used for recalibration was computed by use of the reduced major-axis regression method [ 11 , 12 ] . For reference materials that have just a single level, the ratio of the assigned value to average measured values was used for recalibration.
Statistical analyses Analyses for sources of variations and partitioning criterion
The test results were evaluated by use of the same statistical procedures employed in the previous study [ 9 ] . In brief, sources (factors) of variations were analyzed by three-level nested ANOVA (3N-ANOVA).
The factors considered were sex, region, age, and BMI. Primarily, the fi rst three factors were analyzed; then, aft er separating data by sex, the analyses using the last three factors were performed. The magnitude of variation due to each factor is expressed as a standard deviation (SD): i.e., between-region SD (SD reg ), between-sex SD (SD sex ), and between-age SD (SD age ). In the analysis, regions were categorized into 14 areas (7 within Japan, 7 outside Japan), age was stratifi ed into four groups (20 -29, 30 -39, 40 -49, and 50 -65 years), and BMI was separated into six categories by setting the following boundary values: 18, 20, 22, 24, and 26 kg/m 2 . The relative magnitude of each variable to that of the residual SD representing a net between-individual SD (SD net-btw-indiv ), which roughly corresponds to one quarter of the width of the RI obtained aft er adjusting for the infl uence of age and sex, was computed as the SD ratio (SDR) by the following formula:
An SDR of ≥ 0.3 was regarded as high, requiring partition of reference values by the factor [ 13 ] . Meanwhile, an SDR between 0.25 and 0.29 was considered moderate in degree. In the above computation, when the distribution of the test results was skewed and had a long upper tail, the values were logarithmically transformed before 3N-ANOVA was applied (as indicated in Table 2 ). In these cases, the back-transformed SD described elsewhere [ 9 ] was used in the above equation. In the analysis of regionality, when computing SDR for region (SDR reg ), test results obtained within Japan were all combined, as were those from the two cities in Taiwan, and those from Hong Kong and Macau, respectively, as single regions. Meanwhile, test results from Seoul, Beijing, Ho Chi Minh City, Kuala Lumpur, and Jakarta were treated as separate regions; thus, the number of regions served for the analysis of SDR reg was eight in all.
Derivation of reference intervals
As a preliminary step to select appropriate reference individuals, those who had extreme values in analytes related to obesity, anemia, infl ammation, and thyroid dysfunction as follows were excluded before the derivation of RIs: 17 pmol/L (1.8 ng/dL), and TSH > 14 mU/L. As for BMI, 65 (1.8%) individuals exceeded the upper limit of 28 kg/m 2 set at the time of recruitment. In consideration of the imprecision of BMI and the availability of related information indicating obesity, the final exclusion criterion was set as a BMI of ≤ 14 or ≥ 30 kg/m 2 . Thus, 21 individuals were excluded by these BMI extremes.
The RIs were derived parametrically by use of modifi ed Box-Cox transformation [ 14 ] , which invariably succeeds in transforming reference values into those of Gaussian distribution as long as there are not many results that are below the detectable limits [ 13 ] . As a tertiary exclusion step to further refi ne the reference values, an iterative approach called the ' latent abnormal values exclusion ' (LAVE) method was applied for the actual derivation of the RIs [ 7 , 13 , 14 ] . As exclusion criteria, the RIs of the following 13 analytes were used: Alb, Glb, UA, Glu, AST, ALT, LD, GGT, CK, TG, HDL-C, LDL-C, and CRP. In short, the initial RIs were derived analyte by analyte independently of the results of the others. From the second iteration, the RIs for the above exclusion criteria analytes obtained at the previous cycle of iteration were used to exclude individuals who had abnormal results in analytes other than the one being evaluated. In applying the exclusion criteria, the RIs were extended on both ends by 5% of the interval, or (upper limit -lower limit) × 0.05. Therefore, when the test results are normally distributed, results outside of the mean ± 2.16 SD (total of 3% on two tails) are regarded as abnormal. This adjustment was made to avoid excluding too many individuals unnecessarily. The computation was continued until the RIs of all the analytes became stable.
Statistical analyses and 3N-ANOVA was performed with general purpose statistical soft ware StatFlex for Windows Ver. 6.0 (Artech, Osaka, Japan). Original soft ware named ' Reference Master ' developed by the fi rst author was employed to derive RIs based on the LAVE principle and parametric methods.
Results
Profile of the subjects
The demographic profile of the participants from each city is summarized in Table 3 . The tabulation was made after deleting those with extreme values based on the criteria described in the Methods. As a whole, there were more females than males (1959 vs. 1582). The information on ethnicity was not obtained in Japan, Korea, and China with known homogeneity of the target population in the medical facilities involved. The ethnic composition in other countries was as follows: in Kuala Lumpur: Chinese 36%, Malay 45%, Indian 13%; in Ho Chi Minh City: Vietnamese (Kinh) 98%; in Jakarta: Malay 86%, Chinese 13%.
The between-region differences in age, BMI, and levels of smoking and alcohol use were analyzed by one-way ANOVA separately for each sex. The ratios of pure component of between-region SD divided by residual SD representing between-individual SD in males (females) were 0.10 (0.10) for age, 0.21 (0.22) for BMI, 0.18 (0.17) for smoking, and 0.63 (0.55) for alcohol, respectively. The ratio has the same implication as the SDR described above as a means of computing the magnitude of a given variation source. If we set 0.30 as the practically significant effect size of each factor, only the level of alcohol use was apparently different across the Asian cities, reflecting differences in religion and culture.
The job profile of the reference individuals (n = 3314) after the selection process is shown in Supplementary TableTable 2 The results of three-level nested ANOVA. Trans, transformation. SDR represents the ratio of the standard deviation for a given factor to that for a net between-individual variation. SDR-sex, -reg, and -age denote SDR representing between-sex, -region, and -age differences, respectively . a Harris-Boyd method [15] was used to test for the need of partitioning by sex. The z score representing differences in two means is adjusted to az by multiplying a coefficient (k), which depends on the sample sizes of the two groups. For partitioning of RI, a z ≥ 3.0 is usually considered as significant.
b Three-level nested ANOVA was applied in two stages, first for between-sex, -region, and -age differences, and second for between-region, -age, and -BMI after partitioning by sex. SDR ≥ 0.3 was regarded as a significant between-sex, -city, or -age difference. CI, confidence intervals; Me, median; N o , the number of subjects before the secondary exclusion; N, the number of subjects after the secondary exclusion.
of the reference individuals, whereas the remainder did not provide information on their job.
Standardization of test results
Excellent linearity between the test results and the values assigned to the reference materials with correlation coefficients very close to 1.0 were obtained for all the analytes that were measured in three or more levels ( Supplementary Figure 1 ). The major axis regression was used to compute the regression line for recalibration. The results of reference materials measured at only a single level were used for recalibration by taking their ratio to the assigned values (Supplementary Table 2 ).
Sources of variations and regionality of results
The result of the 3N-ANOVA for all the analytes are summarized in Table 2 . The three factors analyzed were sex, region, and age. Those analytes indicated as ' log ' in the 3rd column were transformed logarithmically before applying 3N-ANOVA. The level of SDR for sex (SDR sex ) was high ( ≥ 0.3) for 19 analytes. In the table, the magnitude of between-sex difference quantified by 3N-ANOVA is compared with that by the Harris-Boyd method [ 12 , 13 ] . The two approaches agreed quite well in almost all analytes. The SDRs for region (SDR reg ) were high in five analytes: HDL-C, CRP, IgG, C3, and C4. SDRs for age (SDR age ) were high in 16 analytes.
Additionally, we noted unmatched regionality between the two sexes when we applied the 3N-ANOVA separately for males and females using the entire dataset, with inclusion of BMI as the third factor. The SDR reg computed for six analytes (urea, TG, IgA, IgM, Tf, and TTR) exceeded 0.3 only in either of the sexes (also shown in Supplementary Table 3A) . As a whole, SDR reg of 11 analytes exceeded 0.3 in either or both of the sexes. This finding implies the importance of separate analysis for both sexes to clearly identify regionality by use of 3N-ANOVA. When data was limited to those obtained from Japan (Supplementary Table 3B ), there were no analytes that showed an SDR of ≥ 0.3. Examples of regional differences for eight analytes with a high SDR reg score (urea, HDL-C, IgG, IgA, C3, C4, and CRP, and Tf) are illustrated in Figure 1 . Similar figures for the entire group of results including the items from questionnaires are also available on-line as Supplementary Figure 2 .
Reference intervals
RIs were derived from the reference individuals after the selection process in three ways: male plus female, male only, and female only, and by use of the modified Box-Cox formula. On the basis of the above results on regionality, when SDR reg was ≥ 0.25, RIs were computed in four ways: all Asians, Japanese, Chinese (Beijing + Taiwan + Hong Kong + Macau), and Southeast Asians (Ho Chi Minh City + Kuala Lumpur + Jakarta); otherwise, RIs were computed from the entire dataset (all Asians), as listed in Table 4 .
In the derivation of RIs, we applied the tertiary exclusion procedure based on the LAVE method. Approximately 13% of the original data were excluded (3314 → roughly 2880 individuals) by the iterative optimization process. The effect of this tertiary exclusion was apparent only for analytes ( Figure 1 Examples of regional differences in test results observed in eight analytes. Each panel consists of two figures, one for males (left) and one for females (right). Test results were sub-grouped into 14 areas: seven from Japan (blue, male; red, female) and another seven from East and Southeast Asia (green, male; orange, female). The regions were aligned from north to south. The box within each scattergram represents the central 50% range, and the vertical line in the middle of the box indicates the median. SDR reg displayed on top of each panel represents SD ratio of between-region variations to the pure between-individual variation. SDR > 0.3 was considered as practically significant. known to be related to the metabolic syndrome (TG, AST, ALT, GGT, and CRP) (Supplementary Table 4 ). For these five analytes, individuals consuming ethanol > 40 g/day and those with BMI > 26 kg/m 2 were excluded before deriving RIs. In addition, in derivation of RIs for IgA, individuals who reported presence of allergic conditions (allergic rhinitis, atopic dermatitis, etc.) in the questionnaire were excluded before the computation. Therefore, the number of reference individuals for those analytes was smaller.
As supplementary information, RIs were computed in total of seven ways (additionally for Taiwan, Hong Kong/ Macau, and Ho Chi Minh City), irrespective of SDR reg values, in both international and conventional units as listed in Supplementary Table 5 . Age-related reference intervals for every 10 years of age for each sex were derived both from data of the entire regions and from data limited to Japan, and were provided as Supplementary Table 6A and B.
Discussion
To avoid the potential influence of differences in occupation on test results, we recruited candidate reference individuals mostly from healthy hospital workers (84%), with the remainder from those who worked indoors. This recruitment policy may give an impression of bias in the population. However, there are a variety of jobs in medical facilities, and the level of physical activity differs widely from one individual to another. Therefore, we believe that the target population actually represents a majority of the general population working mostly indoors. However, if we had sampled more broadly, we could not have distinguished true regional differences from those attributable to occupational environment and degree of labor. To assess the practicality of the RIs derived, further investigation may be required in each geographical area to compare the RIs with those derived based on data obtained in a setting of community health screening.
In defining reference individuals, it is also important to clarify a policy regarding how to exclude those with abnormal results due to latent diseases. Although there are many pathological conditions that may affect the test results of each analyte, we assumed that as long as the prevalence was low, inclusion of results from such cases would not have any influence on the determination of RIs targeting the central 95% interval. In contrast, careful consideration must be given to the exclusion of those individuals with latent but highly prevalent disorders like metabolic syndrome and diabetes. For excluding abnormal results, it is not appropriate to apply clinical decision limits (CDL), generally set by consensus among clinical experts as a guide for prevention of those diseases. Such a univariate approach of excluding abnormal values results in truncation of the reference distribution.
To exclude individuals with abnormal results due to latent diseases, we applied a multivariate approach called the LAVE method [7, 9 , 13 , 14 ] , which is an iterative method for optimized selection of reference individuals. In the initial iteration, it determines RIs analyte by analyte in a univariate manner without consideration of other test results. From the second iteration on, a RI for any given analyte is computed from datasets after excluding the values of individuals who have abnormal results in other analytes. By repeating this process, the RIs are progressively optimized so long as there are associations among the abnormal results. This method applies a principle similar to the one presented by Grossi et al. [ 16 ] based on the correlation among variables. In the present study, we used the RIs of 13 ' basic ' analytes as criteria in judging the need for exclusion: Alb, Glb, UA, Glu, AST, ALT, LD, GGT, CK, TG, HDL-C, LDL-C, and CRP. The LAVE method effectively narrows the RI when there are associations with test results of the ' basic ' analytes set for exclusion criteria (see Supplementary Table 4) , whereas RIs of analytes that lack such association are not affected. The LAVE method also does not cause any change in RIs of analytes for which abnormal results are rare among healthy individuals, (Table 4 Continued) such as Alb, CRE, urea, and Na. As expected, for the analytes in the lipid profile, the obtained results were different from the CDL, which have a different origin and are usually aimed at a specific group of diseases [ 17 ] .
The most conspicuous finding of this study was the detection of no regionality in test results for any of the 31 analytes examined within the entire area of Japan. This implies that it is possible to share RIs nationwide in Japan for the standardized analytes that were made traceable to a reference measurement system. In contrast, when all Asian areas were included in the nested ANOVA, we observed apparent regional differences in five analytes: HDL-C, IgG, C3, C4, and CRP. In regard to inflammatory markers, we reproduced and confirmed the findings of the past two Asian studies [ 7 , 9 ] : the closer the regional area is to the equator, the higher the serum concentrations of positive inflammatory markers (IgG, C3, CRP). This same tendency was also found for C4. It is assumed that exposure to infectious agents is higher in regions closer to the equator.
We were not able to identify the reason for the prominent difference in the level of HDL-C between Japan and the rest of the regions by use of 3N-ANOVA in the second Asian study. However, when we re-analyzed this separately for both sexes, we detected apparent regionality (SDR reg ≥ 0.3) with the same tendency for both sexes: higher HDL-C levels in two cities in Japan compared with four other cities. However, the regionality detected in electrolytes (Na, K, Cl, and Ca) and LD in the second study was not clearly observed this time, although there was a slight tendency for local differences in K and LD from the graph. The much smaller data size in the second study may have been responsible for the inconsistent results. This result poses a question as to the appropriateness of the cut-off value for SDR set at 0.3. In fact, when the SDR reg was computed after separating the dataset by sex, regionality with a SDR reg of ≥ 0.3 was observed in either or both of the sexes in 11 analytes, an increase of six analytes after the separation. Those analytes showing regionality only in males were urea, IgM, TTR, and Tf, and those with regionality only in females were TG and IgA. Furthermore, when we looked at the graphs (Supplementary Figure 2) showing the regional distributions, some of the test results showed a bias limited to just one or two areas. For example, test results for LD are lower in Kuala Lumpur and Jakarta, and those for ALP are higher in these two cities than elsewhere. Therefore, even when SDR reg is well below 0.3, presence of localized bias in test results cannot be denied completely. We must also note that the number of volunteers recruited within Japan was much larger than that outside Japan, and there was no regionality within Japan. Therefore, this imbalance inevitably caused dilution of the effect of regional differences.
To adjust for regional differences in BMI and smoking and drinking habits, we applied multiple regression analyses and confirmed that none of the regionality observed in test results was influenced by the covariates. These results will be reported in the companion article to be published in this series.
Although we emphasized the presence of regionality in the above discussion, we could derive ' common ' RIs valid at least in Southeast Asian countries for the majority of the analytes. As we made the test results traceable to the reference measurement procedures through careful recalibration using certified reference materials, the RIs are in a sense ' universal ' as long as the constitution of the target population and the statistical methodologies do not change.
From the standpoint of traceability, we could make a valid comparison of our results with RIs for AST, ALT, and GGT made traceable to a reference measurement system that was recently derived by the IFCC C-RIDL targeting European and Asian population [ 6 ] .
In conclusion, RIs which can be applicable to a wide geographical area in Asia were established for the majority of analytes with traceability to reference measuring systems, whereas regional partitioning was required for RIs of HDL-C, CRP, IgG, C3, and C4 in both sexes and for urea, TG, IgA, IgM, Tf, and TT in either of the sexes. However, no regional differences were observed in any analyte when data were limited to those from Japan.
